MedTrace Logo

Effects of an Online Training Program for Physiotherapists About Weight Management for People With Osteoarthritis

NCT04574804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2021-07-09

No results posted yet for this study

Summary

A randomized controlled trial for which the primary objective is to evaluate the effects of an online training program on physiotherapist's self-reported confidence in knowledge about weight management for people with osteoarthritis. 80 physiotherapists will be recruited into the study and randomized to one of two arms a) online training program (access to training program for 6 weeks) or b) control group (no access to online training program during the study). Questionnaires will be completed by all participants at baseline, and again at the end of the 6 week intervention period. A biostatistician will analyse blinded, de-identified data.

Conditions

Interventions

OTHER

Online training program in weight management for osteoarthritis

An evidence based online education training program for physiotherapists in weight management for osteoarthritis. Training modules cover the following topic areas: 1. Overweight and obesity and osteoarthritis 2. Overview of weight regulation, overweight and obesity 3. Examining weight stigma in physiotherapy and personal beliefs about weight 4. Communication approach for addressing weight management 5. Interventions for weight management 6. Health behaviour change support These 6 e-learning modules comprise the online training program, access to which comprises the study intervention.

Sponsors & Collaborators

Principal Investigators

  • Kim Bennell, PhD, BAppSci · University of Melbourne

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2020-12-15
Completion
2020-12-15

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04574804 on ClinicalTrials.gov